1. Home
  2. MYGN vs LOCO Comparison

MYGN vs LOCO Comparison

Compare MYGN & LOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$6.29

Market Cap

444.2M

Sector

Health Care

ML Signal

HOLD

Logo El Pollo Loco Holdings Inc.

LOCO

El Pollo Loco Holdings Inc.

HOLD

Current Price

$16.44

Market Cap

411.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYGN
LOCO
Founded
1991
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
444.2M
411.3M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
MYGN
LOCO
Price
$6.29
$16.44
Analyst Decision
Buy
Buy
Analyst Count
7
4
Target Price
$7.64
$14.17
AVG Volume (30 Days)
1.5M
291.3K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
4.65
EPS
N/A
0.27
Revenue
$771,400,000.00
$401,701,000.00
Revenue This Year
$6.86
$3.60
Revenue Next Year
$5.45
$3.98
P/E Ratio
N/A
$61.35
Revenue Growth
2.33
5.68
52 Week Low
$3.53
$8.99
52 Week High
$8.59
$17.40

Technical Indicators

Market Signals
Indicator
MYGN
LOCO
Relative Strength Index (RSI) 70.35 57.75
Support Level $6.09 $15.84
Resistance Level $7.29 $17.40
Average True Range (ATR) 0.34 0.46
MACD 0.02 -0.08
Stochastic Oscillator 93.91 38.46

Price Performance

Historical Comparison
MYGN
LOCO

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

About LOCO El Pollo Loco Holdings Inc.

El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. It specializes in fire-grilling citrus-marinated chicken and operates in the limited service restaurant market segment. Its offerings include Mexican-inspired menu items, including burritos, tostadas, bowls, salads, and bone-in chicken meals in various portion sizes. It also offers citrus-marinated fire-grilled chicken, along with a range of salsas and dressings that allow customers to customize their meals. The company operates in one operating segment. The majority of the company's revenue is derived from company-operated restaurant revenue.

Share on Social Networks: